IPO Year: 2022
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
DEFR14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
DEF 14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
Fastest customizable press release news feed in the world
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19th. Please Schedule 1x1 Meetings here. The presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Presenting Companies CompanyTicker(s)MetaVia Inc.(NASDAQ:MTVA)Nasus Pharma Ltd.(NYSE:NSRX)CytoSorbents Corporation(NASD
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings
ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th TIME: 2:00 pm ET REGISTER HERE Available for 1x1 meetings: June 24-25. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommend
MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t
MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register
4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)
4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)
4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)